The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of intervening in high-risk nonmetastatic castration-resistant prostate cancer (HRnmCRPC) on metastatic castration-resistant prostate cancer (mCRPC) disease burden.
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Fortis; Gilead Sciences; Valeant Pharmaceuticals International
Research Funding - Janssen (Inst)
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Janssen Oncology; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Ying Zheng
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Feng Pan
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Maneesha Mehra
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Joe Lawson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Boris A. Hadaschik
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen
Research Funding - Astellas Pharma; Bristol-Myers Squibb; German Cancer Aid; German Research Foundation; Janssen; Profound Medical
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen
 
Hiroji Uemura
No Relationships to Disclose
 
Ji Youl Lee
No Relationships to Disclose
 
Paul N. Mainwaring
Stock and Other Ownership Interests - Xing Technologies
Honoraria - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech
Research Funding - Merck KGaA
Patents, Royalties, Other Intellectual Property - 4 patents on nanotechnology
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Bayer; Gilead Sciences; Janssen Oncology; Pfizer
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst)